Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy-Reference-Cited by-同舟云学术

Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy

Published:2023-07-21 Issue:9 Volume:43 Page:1064-1068
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Shi Yaoping¹,Shi Donghua¹,Chi Jiachang¹,Cui Dan¹,Tang Xiaoyin¹,Lin Yan¹,Wang Siying²,Li Zonghai²³,Jin Haojie²^ORCID,Zhai Bo¹

Affiliation:

1. Department of Interventional Oncology, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital Shanghai Jiao Tong University School of Medicine Shanghai P. R. China

2. Shanghai Cancer Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital Shanghai Jiao Tong University School of Medicine Shanghai P. R. China

3. CARsgen Therapeutics Ltd. Shanghai P. R. China

Funder

Program of Shanghai Subject Chief Scientist

Program of Shanghai Academic Research Leader

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12472

Reference9 articles.

1. Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey